IMCD Stock

IMCD EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of IMCD (IMCD.AS) as of Aug 6, 2026 is 14.84. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 12.72 — a change of 16.61% (higher).

EV/EBIT

14.84

YoY

16.61%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of IMCD is 2026 14.84 . EV/EBIT (Enterprise Value to EBIT) of IMCD was 2025 12.72 . It decreases by 16.61% higher compared to the previous year.

The IMCD EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
23.19 base
Jan 1, 2020
30.93 base
Jan 1, 2021
36.30 base
Jan 1, 2022
16.48 base
Jan 1, 2023
20.99 base
Jan 1, 2024
19.44 base
Jan 1, 2025
12.54 base
Jan 1, 2026 (e)
12.31 base
YEARPRICE-TO-EBIT
2026 est 12.31
2025 12.54
2024 19.44
2023 20.99
2022 16.48
2021 36.30
2020 30.93
2019 23.19
2018 18.06
2017 21.96
2016 17.76
2015 19.63
2014 17.05
2013 -
2012 -
2011 -
Access this data via the Eulerpool API

IMCD Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides IMCD's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates IMCD's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots IMCD's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if IMCD grows earnings faster than its peers.

IMCD Stock analysis

What does IMCD do? IMCD NV is a leading global distributor of specialty chemicals and food ingredients with over 100 years of experience in the industry. The company, founded in 1995, is headquartered in Rotterdam, Netherlands, and operates business in over 50 countries worldwide. History: IMCD was founded as an intermediary for pharmaceuticals and specialty chemicals, initially under the name Internatio-Müller. The company grew rapidly and expanded its product offering. In 1995, the company was renamed IMCD and began to further diversify in various areas, including Coatings & Construction, Life Sciences, Personal Care, and Food & Nutrition. Business model: IMCD offers a wide range of specialty and raw materials from leading manufacturers. The company provides customized services, including consultation, logistics, and technical support. They work closely with their customers and suppliers to support product development and application solutions. Segments: IMCD is divided into five main areas: Pharmaceuticals, Coatings & Construction, Life Sciences, Personal Care, and Food & Nutrition. Pharmaceuticals: IMCD offers a wide range of active ingredients, excipients, and granulates for the pharmaceutical industry. This includes API's (Active Pharmaceutical Ingredients), excipients, additives, and formulations. The products are offered for most areas of human and veterinary pharmacy. Coatings & Construction: IMCD offers solutions for the areas of paints, coatings, and construction. The company has extensive expertise in the formulation of coatings, paints, and coatings, as well as application technology and software-based color measurements. Life Sciences: IMCD offers a comprehensive range of specialty chemicals and raw materials for biotechnology, diagnostics, and analytics. The products are suitable for applications in medical diagnostics, biopharmaceutical production, and medical research. Personal Care: IMCD is a major supplier of raw materials and formulations for fragrant cosmetics, skincare, haircare, oral care, sun protection, and soaps. Food & Nutrition: IMCD offers a wide range of raw materials, ingredients, and additives for the food and beverage industry. This includes various ingredients such as emulsifiers, stabilizers, acid regulators, dyes, sweeteners, flavors, and dietary supplements. Products: IMCD offers a wide range of products used in various industries. In addition to the mentioned categories, IMCD also distributes solutions for the industrial sector, construction chemistry, environment, and energy. Their products include specialty chemicals, raw materials, formulations, and additives for all application areas, as well as technical manufacturing process and application technology, as well as laboratory and test reports. Some of the most well-known brands in their portfolio include Evonik, Huntsman, DSM, Solvay, and L'Oréal. In summary, IMCD is an important distributor and partner for numerous companies worldwide. With a diverse product portfolio and technical know-how, they support their customers in the development and production of innovative solutions. IMCD is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IMCD stock

EV/EBIT (Enterprise Value to EBIT) of IMCD is 14.84 in 2026.

EV/EBIT (Enterprise Value to EBIT) of IMCD changed from 12.72 to 14.84, representing a 16.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) IMCD since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s IMCD with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — IMCD

All Key Metrics — IMCD